Basic Information
Developer of a biotech company planning to produce nucleotide sugars. The company is designing biocatalysts to manufacture human milk oligosaccharides and customize the glycosylation of therapeutic proteins, enabling biotechnology experts to offer orders at scales with lower production costs than currently available.
eversyn GmbH
Magdeburg,Saxony-Anhalt,Germany
less than 15 people
January 01, 2022
info@eversyn.de
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios